| South Lincoln Medical Center - Cah | |
| 711 Onyx Street, Kemmerer, Wyoming 83101 | |
| (307) 877-4401 | |
| Not Available |
| Name | South Lincoln Medical Center - Cah |
|---|---|
| Type | Critical Access Hospital |
| Location | 711 Onyx Street, Kemmerer, Wyoming |
| Ownership | Government - Hospital District or Authority |
| Emergency Services | Yes |
| Medicare ID (CCN) | 531315 |
| NPI Number | 1710081260 |
| Organization Name | SOUTH LINCOLN HOSPITAL DISTRICT |
| Doing Business As | SOUTH LINCOLN MEDICAL CENTER |
| Address | 711 Onyx Street, Kemmerer, WY 83101 |
| Hospital Type | General Acute Care Hospital - Rural |
| Phone Number | 307-877-4401 |
News Archive
Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.
While most research aimed at developing carbon nanotubes as tumor-targeting drug and imaging agent delivery vehicles has focused on full-length nanotubes, Lon Wilson, Ph.D., and his colleagues at Rice University have been working with ultra-short nanotubes that cells appear to take up more efficiently than their longer counterparts.
The Engineering and Physical Sciences Research Council (EPSRC) will help the UK's world-leading researchers in synthetic biology to establish platform technology in the emerging field with a new grant of almost -5 million. Platform technology is the crucial next step necessary for applications to be produced and commercialised.
The UK's national synchrotron facility, Diamond Light Source, is now the first and only place in Europe where pathogens requiring Containment Level 3 - including serious viruses such as those responsible for AIDS, Hepatitis and some types of flu - can be analysed at atomic and molecular level using synchrotron light.
For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
› Verified 6 days ago
| NPI Number | 1972743011 |
| Organization Name | SOUTH LINCOLN HOSPITAL DISTRICT |
| Doing Business As | SOUTH LINCOLN MEDICAL CENTER |
| Address | 711 Onyx St, Kemmerer, WY 83101 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 307-877-4401 |
News Archive
Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.
While most research aimed at developing carbon nanotubes as tumor-targeting drug and imaging agent delivery vehicles has focused on full-length nanotubes, Lon Wilson, Ph.D., and his colleagues at Rice University have been working with ultra-short nanotubes that cells appear to take up more efficiently than their longer counterparts.
The Engineering and Physical Sciences Research Council (EPSRC) will help the UK's world-leading researchers in synthetic biology to establish platform technology in the emerging field with a new grant of almost -5 million. Platform technology is the crucial next step necessary for applications to be produced and commercialised.
The UK's national synchrotron facility, Diamond Light Source, is now the first and only place in Europe where pathogens requiring Containment Level 3 - including serious viruses such as those responsible for AIDS, Hepatitis and some types of flu - can be analysed at atomic and molecular level using synchrotron light.
For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
› Verified 6 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.
While most research aimed at developing carbon nanotubes as tumor-targeting drug and imaging agent delivery vehicles has focused on full-length nanotubes, Lon Wilson, Ph.D., and his colleagues at Rice University have been working with ultra-short nanotubes that cells appear to take up more efficiently than their longer counterparts.
The Engineering and Physical Sciences Research Council (EPSRC) will help the UK's world-leading researchers in synthetic biology to establish platform technology in the emerging field with a new grant of almost -5 million. Platform technology is the crucial next step necessary for applications to be produced and commercialised.
The UK's national synchrotron facility, Diamond Light Source, is now the first and only place in Europe where pathogens requiring Containment Level 3 - including serious viruses such as those responsible for AIDS, Hepatitis and some types of flu - can be analysed at atomic and molecular level using synchrotron light.
For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
› Verified 6 days ago
South Lincoln Medical Center - Cah Critical Access Hospital Location: 711 Onyx Street, Kemmerer, Wyoming 83101 Phone: (307) 877-4401 |